𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Efficacy of amphotericin B or amphotericin B–intralipid in combination with caspofungin against experimental aspergillosis

✍ Scribed by Edward Sionov; Sonia Mendlovic; Esther Segal

Book ID
108174374
Publisher
Elsevier Science
Year
2006
Tongue
English
Weight
555 KB
Volume
53
Category
Article
ISSN
0163-4453

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and toxicity of caspofungin in
Efficacy and toxicity of caspofungin in combination with liposomal amphotericin B as primary or salvage treatment of invasive aspergillosis in patients with hematologic malignancies
✍ Dimitrios P. Kontoyiannis; Ray Hachem; Russell E. Lewis; Gustavo A. Rivero; Harr 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 1 views

## Abstract ## BACKGROUND Caspofungin (CAS) as salvage therapy for refractory invasive aspergillosis (IA) had a response rate of 45% among a heterogeneous group of patients. The use of CAS with other agents is appealing given its unique mechanism of action. Therefore, the authors retrospectively e

Assessing the antifungal activity and to
Assessing the antifungal activity and toxicity profile of amphotericin B lipid complex (ABLC; Abelcet®) in combination with caspofungin in experimental systemic aspergillosis
✍ Olena Sivak; Karen Bartlett; Verica Risovic; Eugene Choo; Fawziah Marra; D. Scot 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

The purpose of this study was to assess the antifungal activity and renal and hepatic toxicity of amphotericin B lipid complex (ABLC; Abelcet 1 ) following coadministration of Caspofungin to rats infected with Aspergillus fumigatus. Aspergillus fumigatus inoculum (1.3-2.3 Â 10 7 colony forming units

Liposomal amphotericin B in combination
Liposomal amphotericin B in combination with caspofungin for invasive aspergillosis in patients with hematologic malignancies : A randomized pilot study (Combistrat trial)
✍ Denis Caillot; Anne Thiébaut; Raoul Herbrecht; Stéphane de Botton; Arnaud Pigneu 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 122 KB 👁 1 views

## Abstract ## BACKGROUND. Invasive aspergillosis (IA) has a poor prognosis in immunocompromised patients. Combinations of drugs that act on different targets are expected to improve the clinical efficacy of separate compounds. ## METHODS. Patients with proven or probable IA were randomized in a